Filing search / Day One Biopharmaceuticals, Inc. / "Access" / Page 3

424B5

gag5f80j7 hqaq52hp

7 Jun 23

Prospectus supplement for primary offering

4:57pm

424B5

cof ig1txd1

6 Jun 23

Prospectus supplement for primary offering

4:21pm

8-K

EX-99.2

vjteulp

5 Jun 23

Regulation FD Disclosure

6:08am

8-K

EX-99.1

b3mujj8 u98fey67mc5t

5 Jun 23

Regulation FD Disclosure

6:08am

8-K

EX-99.2

tzjlvkd

1 May 23

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

9:01am

8-K

EX-99.1

uws474nrkp6dfy2n6i

1 May 23

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

9:01am

PRE 14A

rs5d1q6nx i322lib

18 Apr 23

Preliminary proxy

4:05pm

8-K

EX-99.2

u8ny2znrt9obc

7 Nov 22

Day One Reports Third Quarter 2022 Financial Results and Corporate Progress

4:31pm

8-K

EX-99.2

s8dzmsls

12 Sep 22

Day One Appoints Garry Nicholson as Chairman of the Board of Directors

8:40am

8-K

EX-99.2

72dsi kede11k

4 Aug 22

Day One Reports Second Quarter 2022 Financial Results and Corporate Progress

4:53pm

8-K

EX-99.1

qnbhhrijn ifzrv

24 Jun 22

Submission of Matters to a Vote of Security Holders

4:06pm

8-K

EX-1.1

77ssey

16 Jun 22

Day One Announces Pricing of Upsized Public Offering of Common Stock

7:33am

424B5

6vibx jwdr

16 Jun 22

Prospectus supplement for primary offering

7:30am

424B5

9630kin

14 Jun 22

Prospectus supplement for primary offering

7:39am

8-K

EX-99.2

i7c4 jm48

13 Jun 22

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

6:24am